Insilico Medicine vs Tempus

Side-by-side comparison of Insilico Medicine and Tempus: pricing, features, API access, and community ratings.

AI comparison summary

Generating comparison…

	Insilico Medicine Generative AI platform for end-to-end drug discovery, from target identification to clinical trials Visit	Tempus AI-powered precision medicine platform for oncology and clinical insights Visit
Category	Healthcare & biotech	Healthcare & biotech
Pricing	Enterprise	Enterprise
Starting price
Free tier
Audience	Technical	All audiences
API available
Open source
Self-hostable
Model provider	Insilico Medicine (proprietary LLLMs)	Proprietary
Founded	2014	2015
Headquarters	Cambridge, USA	Chicago, USA
Key strengths	·End-to-end AI-driven drug discovery pipeline (target ID to clinical trials) ·Generative chemistry and biology AI (Chemistry42, Generative Biologics) ·Large Language of Life Models (LLLMs) for biomedical research ·Validated therapeutic pipeline with programs in Phase I/II trials	·One of the world's largest clinico-genomic databases ·AI-driven oncology insights and companion diagnostics ·Real-time data integration across genomics, imaging, and EHR ·Supports physicians with treatment decision support